Private Equity (PE) firm Havencrest has completed a majority recapitalization of a Pediatric Dentistry｜Pedodontics anesthesia services provider.Issuing time:2026-04-10 15:03
DentalGoodNews｜On April 9, 2026, Dallas-based healthcare-focused Private Equity (PE) firm Havencrest Capital Management (hereinafter referred to as "Havencrest") announced the completion of a majority recapitalization* of pediatric dental anesthesia services provider OFFOR Health (hereinafter referred to as "OFFOR"). The specific financial terms of the transaction were not disclosed. In this transaction, Bass, Berry & Sims PLC served as legal counsel to Havencrest, Ziegler served as financial advisor to OFFOR, and Cascadia Capital served as financial advisor to Havencrest. Through this recapitalization, Havencrest can assist OFFOR in expanding the coverage of its clinical innovation services. Christopher Bowers, who has decades of experience in the payer services market and managed care, will continue to serve as Chairman of the Board of OFFOR upon completion of the transaction. As of press time, the company has not disclosed the latest valuation following this round of recapitalization. Founded in 2014 and headquartered in Columbus, Ohio, OFFOR is a provider dedicated to offering in-office anesthesia services for complex pediatric dental procedures. The company deploys highly integrated clinical teams—including anesthesiologists, PACU nurses, and emergency personnel—along with hospital-grade safety redundancy equipment directly to dental offices. This enables children, including those enrolled in Medicaid, to receive timely treatment, thereby reducing wait times for hospital operating rooms. Havencrest is a healthcare-focused Private Equity (PE) firm with over $600 million in assets under management (AUM). The firm primarily partners with founder-owned healthcare businesses and, in 2022, raised a $356 million fund, Havencrest Healthcare Partners II, LP, for investment.
Article classification:
Investment & Funding
【GOODNEWS】 Content for industry reference only (based on public info & professional judgment); not for decision-making. Readers bear full responsibility for their own judgment and risks.
Copyright © This Platform. Unauthorized reproduction & commercial use prohibited.
Errata, contributions & cooperation: Contact customer service via WeChat:HDSW_001
|
✉️
Subscribe to Our
Newsletter
We curate important stories and exclusive insights, delivered straight to your inbox.
In-depth analysis · Exclusive content · Fast-moving news
|
